Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Articles about Biotechnology, Pharmaceutical and Healthcare

17:02 EDT 20th April 2014 | BioPortfolio

Latest Articles on life science, biotechnology, pharmaceutical and healthcare topics and current issues.

Showing News Articles 1–25 of 26,000+

Friday 18th April 2014

Top Employer Reasons for Switching to Defined Contribution Model

A new research brief from the Prudential Insurance Company of America has revealed that nearly half (47%) of U.S. employers have reported that they are moving or have moved to a Defined Contribution model for healthcare benefits. This is according to Group Benefits and the Defined Contribution Model from Prudential’s Eighth Annual Study of Employee […]The post Top Employer Reasons for Swit...

Breaking News: Cubist Recalls Cubicin Lot

Cubist Pharmaceuticals Inc.Read more about Breaking News: Cubist Recalls Cubicin Lot

Expanded Water Purification Portfolio

Thermo Fisher Scientific Inc. has launched the Thermo Scientific Barnstead GenPure xCAD Plus water purification system, featuring advanced technology that allows simultaneous dispensing from three remote dispensers for exceptional flexibility and ease of use in shared laboratory environments.Read more about Expanded Water Purification Portfolio

Vitamin B3 Might Have Been Made in Space, Delivered to Earth by Meteorites

Ancient Earth might have had an extraterrestrial supply of vitamin B3 delivered by carbon-rich meteorites, according to a new analysis by NASA-funded researchers.

Cloning Making a Comeback?

Read more about Cloning Making a Comeback?Comments

Top French Advisor Resigns Amid Drug Industry Scandal

Read more about Top French Advisor Resigns Amid Drug Industry Scandal

Washington University Launches Immunology Center

Read more about Washington University Launches Immunology Center

Bio-Industry Action Summit to Offer Insight Into Value Added Business Opportunities

Business, technology and agriculture will converge on May 21 at North Dakota State University where attendees will learn about business opportunities and economics of regional bio-based products and materials at the Future of the Bio-Industry Action Summit more

New Pain Relief Targets Could Benefit Cancer Patients

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain.

Progress, Challenges As Medicaid Rolls Swell in Wash.

Washington state has blown past its targets for signing up new Medicaid participants under the Affordable Care Act (ACA). The program’s ranks have grown roughly 25 percent in the past six months, helping fulfill one of the act’s key goals to provide health care to nearly all Americans. By the end of March, more than 285,000 adults who are newly eligible to participate in Medicaid had s...

Phase 1/2 Results Positive for Cancer Drug

XBiotech is announcing that results from its Phase 1/2 oncology study conducted at MD Anderson Cancer Center in Houston, TX were published in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix, XBiotech’s novel, non-cytotoxic, anti-tumor therapy. The so-called true human antibody therapy was reported to have an excellent safety profile...

Ivabradine Fast Tracked for Chronic HF

The U.S. Food and Drug Administration (FDA) has granted fast track designation for investigational ivabradine for patients with chronic heart failure (HF).

Lost Stem Cells Naturally Replaced by Non-stem Cells

Read more about Lost Stem Cells Naturally Replaced by Non-stem CellsComments

Anti-Seizure Drug Could Reduce Alcohol Consumption

Researchers from Boston University School of Medicine (BUSM) have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model.

Actavis to Acquire New Products from Akorn

Actavis plc announced that it has entered into agreements with Akorn Inc. and Hi-Tech Pharmacal Co. Inc.Read more about Actavis to Acquire New Products from Akorn

Multi-Target TB Drug May Treat Other Diseases, Evade Resistance

Read more about Multi-Target TB Drug May Treat Other Diseases, Evade Resistance

Physician Groups Deciding How To Spend Health Care Dollars

The New York Times: Cost Of Treatment May Influence Doctors Saying they can no longer ignore the rising prices of health care, some of the most influential medical groups in the nation are recommending that doctors weigh the costs, not just the effectiveness of treatments, as they make decisions about patient care. The shift, little noticed outside the medical establishment but already controversi...

Are Exchanges More Appealing To Insurers Now?

Elsewhere, in Colorado, new fees on consumers and insurance plans would raise $13 million to help run that state's exchange next year. Modern Healthcare: Exchanges Look More Appealing To Insurers Second Time Around  Health insurers appear to be increasingly bullish on the fledgling state and federal exchanges, in spite of disastrous rollouts in many of the online marketplaces last fall (Demko...

California Officials Announce Enrollee Tally, Note Last-Minute Surge

Covered California, the state's online health insurance marketplace, signed up 200,000 people for coverage during the two-week deadline extension -- bringing the state's total to 1.4 million. The state's initial goal was about 815,900 for the six-month enrollment period that began Oct. 1, 2013.   Los Angeles Times: Obamacare Enrollment Nears 1.4 Million...

Sign-Up Figures Trigger New Round Of Health Law Political Spin

President Barack Obama uses the new enrollment numbers to urge Democrats to be proud of the health law and call on Republicans to back off in their push to repeal the measure. GOP leaders, though, did not appear to soften their positions. CNN: Obama: Republicans 'Were Wrong' About Obamacare President Barack Obama called on his fellow Democrats to "forcefully defend and be proud" of the fact that m...

At 8 Million Sign-Ups, Health Law Enrollment Surpasses Target

President Barack Obama hailed the latest tally of people who gained insurance as a result of the health law. News outlets also look inside this latest round of data to find out what information the administration is providing and what is still to come.    The New York Times: Enrollments Exceed Obama’s Target For Health Care Act President Obama announced Thursday...

Obama Presses Scrutiny Of 2015 Health Insurance Rates

The president made his appeal to state insurance commissioners at a meeting Thursday. Elsewhere, consumer spending related to the health law jumps, the GOP again demands to know the White House's involvement in the rollout, and hospitals try their hand as insurers. The Seattle Times: Kreidler: 'Robust Discussion' With Obama On Health Coverage President Obama, in a meeting with state...

Sebelius Says No To Kansas Senate Run

Despite recent appeals from Democrats for outgoing Health and Human Services Secretary Kathleen Sebelius to run against Sen. Pat Roberts, R-Kan., she has declined. Meanwhile, The New York Times reports that political attack ads are now trying to offer positive alternatives. The New York Times: Sebelius Says She’s Not Interested In Senate Run Kathleen Sebelius, the soon-to-be former secretary...

UnitedHealth Cites Health Law, Costly Hepatitis Drug In Reporting Lower Earnings

The health law's effect was mixed, officials said, because the company did not participate in many of the online marketplaces, but it did see more customers for its Medicaid plans. Officials are considering a bigger role in the marketplaces next year. The New York Times: Health Law Bellwether, UnitedHealth Posts Lower Profit The UnitedHealth Group, one of the nation's largest health insurers, repo...

Highlights: Marathon Bombing Lessons For Hospitals; Ore. Providers Get Less From Medicare; Diabetes Telemedicine in Miss.

A collection of health policy stories from Massachusetts, Oregon and Mississippi. Reuters: A Year After Marathon Bombs, Boston Hospitals Apply Lessons Learned  The homemade bombs that ripped through the crowd at the finish line of last year's Boston Marathon, killing three people and injuring 264, showcased the city's medical talent but also taught valuable lessons in responding to a mass dis...

Search BioPortfolio: